Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Alexion Pharmaceuticals
This publication has 30 references indexed in Scilit:
- Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registryBMC Musculoskeletal Disorders, 2019
- Neurological symptoms in HypophosphatasiaOsteoporosis International, 2018
- HypophosphatasiaCurrent Osteoporosis Reports, 2016
- Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatmentNature Reviews Endocrinology, 2016
- Clinical spectrum of hypophosphatasia diagnosed in adultsBone, 2013
- Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase geneBone, 2007
- A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia.Proceedings of the National Academy of Sciences, 1988
- Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism.Journal of Clinical Investigation, 1985
- Effect of Pyrophosphate on Hydroxyapatite and Its Implications in Calcium HomeostasisNature, 1966
- EXCRETION OF INORGANIC PYROPHOSPHATE IN HYPOPHOSPHATASIAThe Lancet, 1965